Sagimet Biosciences Inc.
SGMTNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $507.77M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.50$11.45
- Volume (live)
- -
- Avg. volume (3M)
- 1.48M
Sagimet Biosciences (SGMT) Stock Price & Financial Analysis
Sagimet Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.41 - $9.70 |
|---|---|
| 52-Week High | $11.45 |
| 52-Week Low | $4.50 |
| Open | $9.61 |
| Volume (last close) | 767.18K |
| Average Volume (3M) | 1.48M |
| 50-Day MA | $9.93 |
|---|---|
| 200-Day MA | $7.33 |
| 1-Year Change | +35.74% |
| Market Cap | 507.77M |
|---|---|
| Shares Outstanding | 53.11M |
| Price to Book (P/B) | 1.98 |
| EV/EBITDA | -6.93 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Sagimet Biosciences at a Glance
As of the Oct 26, 2026 close, Sagimet Biosciences (SGMT) has a market capitalization of $507.77M.
As of its latest reported balance sheet, it holds $165.90M in cash and securities against $1.94M of debt, a net cash position of $163.96M.
Sagimet Biosciences does not currently pay a dividend.
The share price is up 35.7% over the past year. At $9.56 (the Oct 26, 2026 close) it sits within its 52-week range of $4.50 to $11.45, above its 200-day moving average of $7.33.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $28.46, 197.7% above the Oct 26, 2026 close.
Frequently Asked Questions About Sagimet Biosciences
What is the current stock price for SGMT?
As of the Oct 26, 2026 close, SGMT stock trades at $9.56. The 52-week range is $4.50–$11.45, with a day range of $9.41–$9.70.
What is the P/E ratio for SGMT?
The P/E ratio (Price-to-Earnings) for SGMT is shown in the Key Statistics section. This valuation metric helps compare Sagimet Biosciences Inc. to industry peers.
Does SGMT pay dividends?
Sagimet Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SGMT?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for SGMT is Buy. The average 12-month price target is $28.46, a 197.7% upside from the Oct 26, 2026 close of $9.56.
What is the market cap of SGMT?
As of the Oct 26, 2026 close, Sagimet Biosciences's market capitalization is $507.8M, classifying it as a small-cap company. Sagimet Biosciences operates in the Healthcare sector within the Biotechnology industry.